Open Orphan Chief Commercial Officer Maurice Treacy talks about the 5 early adopters of the Genomic Health DataBANK platform.
Mr. Treacy said: “It’s really important that we bring them on board because they’re a combination of pharma companies, biotech, large and small, and they’re all pretty much in the orphan space so they know the challenges we have the genetics and unravelling the genetics of rare disease”.
Commenting on the benefits of platform for companies, he said: “This research tool can really help them have a complete spectrum of products in pre-clinical and clinical evaluation”